Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)
Part of paid clinical trials in New York, New York.
- Sponsor
- New York State Psychiatric Institute
- Study ID
- NCT05477901
- Status
- Recruiting
Conditions
- CBCL
- Family Relations
- HPA
- Inflammation
Eligibility Criteria
- Sex
- ALL
- Age
- 23 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Supplemental cash transfer — OTHERSupplemental cash transfer ($40/month)
Study Details
This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT. Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol. Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.
Key Dates
- Start date
- May 28, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 450 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: InterventionHigh supplemental transfer: $40 a month
- No Intervention: ControlLow supplemental transfer: $2 a month
Primary Outcome Measure
Adverse Childhood Experiences (ACEs) - FHE [ Time Frame: Baseline ]
Central Contacts
- Cristiane Duarte, PhD646-774-5801
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York State Psychiatric Institute | New York | New York | 10032 |
Find similar trials in New York, NY
Related Studies
- Stress Phenotypes and Preterm BirthRecruiting · Columbia University · New York, New York
- Reducing Frailty for Older Cancer Survivors Using Supplements IIPHASE2 · Recruiting · University of Rochester · Rochester, New York
- Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of CancerPHASE2 · Recruiting · University of Rochester · Rochester, New York
- Evaluation and Long-Term Follow-up of Patients With Inflammatory DisordersEnrolling By Invitation · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland